Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Summary Keywords glucagon like peptide-1, irritable bowel syndrome, pain, IBS, agonist Citation Mostafa MEA and Alrasheed T (2025) Improvement of irritable bowel syndrome with glucagon like peptide-1 receptor agonists: a systematic review and meta-analysis
Expected Outcomes Based on Clinical Evidence FDA-approved semaglutide clinical trial data: The STEP 1 trial demonstrated 14.9% average body weight loss over 68 weeks when combined with reduced-calorie diet and increased physical activity
When signaling becomes impaired, luteinizing hormone levels may fall, leading to decreased testosterone production
Mounjaro is convenient to use, with pre-filled injection pens that allow for easy self-injection at home
As the use of semaglutide continues to grow worldwide, especially in people managing chronic diseases like diabetes and obesity, it is important to learn about all of its possible effectsboth good and bad
